2022
DOI: 10.1016/j.survophthal.2021.05.013
|View full text |Cite
|
Sign up to set email alerts
|

Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(28 citation statements)
references
References 306 publications
0
28
0
Order By: Relevance
“…Central nervous system and orbital infiltration by malignant histiocytes manifesting as neurologic deficits and exophthalmos has been seen in about 40% and 25%, in ECD, respectively 3,5 . Ocular involvement has been documented around 30% of cases with ECD which could manifest as uveities, retinal detachment, corneal infiltration by histiocytics, optic disc oedema and vitreitis 6 …”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Central nervous system and orbital infiltration by malignant histiocytes manifesting as neurologic deficits and exophthalmos has been seen in about 40% and 25%, in ECD, respectively 3,5 . Ocular involvement has been documented around 30% of cases with ECD which could manifest as uveities, retinal detachment, corneal infiltration by histiocytics, optic disc oedema and vitreitis 6 …”
Section: Resultsmentioning
confidence: 99%
“…Immunohistochemistry showed that the histiocytes were positive for CD68, CD163 (Fig 3C) and negative for BRAF V600E . An initial diagnosis of ECD was entertained based on histopathologic features of the biopsy and clinical findings since ophthalmologic involvement manifesting as exophthalmos and ophthalmoplegia has been reported in around 30% of patients with ECD 6 . Targeted NGS using the Tempus xT ® targeted panel was pursued, but the test failed due to inadequate tissue sample.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The patient was treated with interferon-α 5. At 1-year follow-up, the symptoms of dyspnoea were significantly relieved, and the pericardial effusion was significantly reduced (online supplemental videos).…”
Section: Answer: Cmentioning
confidence: 99%